生物医药产业作为我国战略性产业,近年得到高速发展,尤其是在2008、2009年间,该产业在所有制造业中是发展最快的。在取得显著成绩之时,还应看到其发展中的问题。生物产业目前面临的问题:一是从规模上看,与发达国家相差较大。资料显示,我国最大的医药企业销售额2008年仅为200亿人民币,而美国安近生物医药公司销售额达到130多亿美元,辉瑞制药销售额达到300亿美 As a strategic industry in China, the biomedical industry has witnessed rapid development in recent years. Especially in 2008 and 2009, the biomedical industry is the fastest growing in all manufacturing industries. At a time when significant achievements have been made, the developing problems should also be seen. The biological industry is currently facing the problem: First, from a scale point of view, with a big difference between developed countries. Data show that China’s largest pharmaceutical company sales in 2008 was only 200 billion yuan, while the United States nearly biomedical company sales of more than 130 billion US dollars, Pfizer Pharmaceutical sales reached 30 billion US dollars